Cargando…
Clinical and economic evaluation of modulated electrohyperthermia concurrent to dose-dense temozolomide 21/28 days regimen in the treatment of recurrent glioblastoma: a retrospective analysis of a two-centre German cohort trial with systematic comparison and effect-to-treatment analysis
OBJECTIVE: To assess the efficacy and cost-effectiveness of modulated electrohyperthermia (mEHT) concurrent to dose-dense temozolomide (ddTMZ) 21/28 days regimen versus ddTMZ 21/28 days alone in patients with recurrent glioblastoma (GBM). DESIGN: A cohort of 54 patients with recurrent GBM treated wi...
Autor principal: | Roussakow, Sergey V |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5722101/ https://www.ncbi.nlm.nih.gov/pubmed/29102988 http://dx.doi.org/10.1136/bmjopen-2017-017387 |
Ejemplares similares
-
Modulated Electrohyperthermia in Integrative Cancer Treatment for
Relapsed Malignant Glioblastoma and Astrocytoma: Retrospective Multicenter
Controlled Study
por: Fiorentini, Giammaria, et al.
Publicado: (2018) -
Modulated Electrohyperthermia: A New Hope for Cancer Patients
por: Alshaibi, Huda F., et al.
Publicado: (2020) -
Concurrent bevacizumab and temozolomide alter the patterns of failure in radiation treatment of glioblastoma multiforme
por: Shields, Lisa BE, et al.
Publicado: (2013) -
Radiotherapy Plus Concurrent or Sequential Temozolomide for Glioblastoma in the Elderly: A Meta-Analysis
por: Yin, An-an, et al.
Publicado: (2013) -
Putative Abscopal Effect in Three Patients Treated by Combined Radiotherapy and Modulated Electrohyperthermia
por: Chi, Mau-Shin, et al.
Publicado: (2020)